Skip to content

Pediatric Helmet CPAP Pilot Study

Helmet CPAP for Infants and Pediatric Patients With Acute Respiratory Distress

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04764929
Enrollment
5
Registered
2021-02-21
Start date
2021-08-07
Completion date
2023-06-14
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis, Viral, Pneumonia, Viral, Pneumonia, Bacterial

Brief summary

This a research study to find out whether giving Continuous Positive Airway Pressure (CPAP) through a Helmet is the same or better than giving CPAP through a Facemask, Nasal Mask, or Nasal Prongs. CPAP can help kids with lung infections breathe easier. The machine delivers pressurized air, which may help people with lung infections breathe more easily. Doctors routinely use a Facemask, Nasal Mask or Nasal Prongs to give CPAP for kids with lung infections, but the researchers want to know whether using Helmet CPAP is the same or better.

Detailed description

Prior clinical trials have demonstrated efficacy of Helmet CPAP in adults with acute respiratory distress syndrome, superior tolerance and improved respiratory scores compared to nasal/facial CPAP in infants, and no major safety concerns were identified with the use of helmet CPAP. This is a prospective pilot study to (1) determine if infants and pediatric patients requiring CPAP in the PICU will tolerate helmet CPAP for at least four hours, and (2) measure changes in the respiratory rate, oxygen saturation, heart rate and blood pressure over four hours. If helmet CPAP is found to be well tolerated in this small cohort, a larger study comparing it directly to other CPAP interfaces will be conducted.

Interventions

Vyatil nonpowered oxygen tent system

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 5 Years
Healthy volunteers
No

Inclusion criteria

* One month to 5 years of age (inclusive) admitted to the PICU with community acquired pneumonia or bronchiolitis, having been stable on nasal or facemask CPAP for at least four hours but less than 48 hours, and parental informed consent.

Exclusion criteria

* Age less than 1 month or greater than 5 years * Positive for COVID-19 * Need for invasive mechanical ventilation or higher levels of non-invasive ventilation such as bi-level positive airway pressure (BPAP) * Unresponsiveness (GCS 8 or less) * Hypotension as defined as a systolic blood pressure less than 5th percentile for age * Existing head or neck trauma, known or suspected air leak syndrome (pneumothorax, pneumomediastinum, subcutaneous emphysema), known or suspected increased intracranial pressure * Non-English speaking parent

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Tolerated CPAP Helmet for at Least Four HoursFour hoursTolerance is defined as the successful application and maintenance of helmet CPAP without any unplanned, prolonged (\>5 minutes) removals or disruptions.

Secondary

MeasureTime frameDescription
Respiratory Rate4 hoursRespiratory rate will be measured in breaths per minute every hour for four hours.
Heart Rate4 hoursHeart rate will be measured in beats per minute every hour for 4 hours.
Oxygen Saturation4 hoursPulse oxygen saturation will be measured as a percent every hour for 4 hours.
Systolic Blood Pressure4 hoursSystolic blood pressure will be measured in millimeters of mercury every hour for 4 hours.

Countries

United States

Participant flow

Participants by arm

ArmCount
Helmet CPAP
Patients in the Pediatric Intensive Care Unit (PICU) already receiving CPAP through a facemask or nasal prongs or mask for at least four hours but no more than 48 hours will be transitioned to the Vyatil nonpowered oxygen tent system (Rochester, NY) by trained respiratory therapists per the manufacture's instructions: patient's neck circumference will be measured with a soft tape measure to ensure appropriate sizing. The helmet will be connected to at least 30 liters per minute of high flow medical air with an oxygen blender. The expiratory limb will be attached to the positive end expiratory pressure (PEEP) valve (initially set at 5 centimeters of water pressure) connected to a high-efficiency particulate air (HEPA) filter to prevent any viral particles from being released into the environment. A disposable manometer will be used to measure the pressure within the helmet. Once the flow to the helmet interface is on, the helmet will be sealed and secured with the system's arm straps. Helmet CPAP: Vyatil nonpowered oxygen tent system
5
Total5

Baseline characteristics

CharacteristicHelmet CPAP
Admission Diagnosis
Viral Bronchiolitis
3 Participants
Admission Diagnosis
Viral Pneumonia
2 Participants
Age, Categorical
<=18 years
5 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
United States
5 Participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
2 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 5
other
Total, other adverse events
0 / 5
serious
Total, serious adverse events
0 / 5

Outcome results

Primary

Number of Participants Who Tolerated CPAP Helmet for at Least Four Hours

Tolerance is defined as the successful application and maintenance of helmet CPAP without any unplanned, prolonged (\>5 minutes) removals or disruptions.

Time frame: Four hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Helmet CPAPNumber of Participants Who Tolerated CPAP Helmet for at Least Four Hours5 Participants
Secondary

Heart Rate

Heart rate will be measured in beats per minute every hour for 4 hours.

Time frame: 4 hours

Population: Data was not collected thus cannot be analyzed or reported.

Secondary

Oxygen Saturation

Pulse oxygen saturation will be measured as a percent every hour for 4 hours.

Time frame: 4 hours

Population: Data was not collected thus cannot be analyzed or reported.

Secondary

Respiratory Rate

Respiratory rate will be measured in breaths per minute every hour for four hours.

Time frame: 4 hours

Population: Data was not collected thus cannot be analyzed or reported.

Secondary

Systolic Blood Pressure

Systolic blood pressure will be measured in millimeters of mercury every hour for 4 hours.

Time frame: 4 hours

Population: Data was not collected thus cannot be analyzed or reported.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026